Edesa Biotech (EDSA) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Edesa Biotech Revenue Highlights


0

Latest Revenue (Q)

$50.92K

Main Segment (Y)

Product

Main Geography (Y)

Product

Edesa Biotech Revenue by Period


Edesa Biotech Revenue by Year

DateRevenueChange
2024-09-30-100.00%
2023-09-30-100.00%
2022-09-30-100.00%
2021-09-30--100.00%
2020-09-30$328.80K-19.97%
2019-09-30$410.87K93.94%
2018-09-30$211.85K-7.20%
2017-09-30$228.29K-82.05%
2016-09-30$1.27M67.62%
2015-09-30$758.69K103.88%
2014-08-31$372.13K-31.78%
2013-08-31$545.47K90.69%
2012-08-31$286.05K-58.97%
2011-08-31$697.19K-18.44%
2010-08-31$854.84K100.00%
2009-04-30-100.00%
2008-04-30--

Edesa Biotech generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Edesa Biotech Revenue by Quarter

DateRevenueChange
2026-03-31$50.92K100.00%
2025-12-31-100.00%
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31-100.00%
2024-12-31-100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31-100.00%
2023-12-31--100.00%
2023-09-30$-1.12M100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$1.12M100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--100.00%
2021-09-30$-3.51M100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31--100.00%
2020-09-30$500.00-99.55%
2020-06-30$109.98K-0.48%
2020-03-31$110.52K2.52%
2019-12-31$107.80K-73.73%
2019-09-30$410.37K81974.00%
2019-06-30$500.00-99.58%
2019-03-31$117.75K122.04%
2018-12-31$53.03K-2.26%
2018-09-30$54.26K-25.73%
2018-06-30$73.05K14.05%
2018-03-31$64.05K212.65%
2017-12-31$20.49K611.35%
2017-09-30$2.88K-85.97%
2017-06-30$20.53K-67.42%
2017-03-31$63.02K-55.58%
2016-12-31$141.86K-48.62%
2016-09-30$276.10K52.47%
2016-06-30$181.09K-44.51%
2016-03-31$326.33K-33.15%
2015-12-31$488.16K143.29%
2015-09-30$200.65K27.20%
2015-06-30$157.75K-15.92%
2015-03-31$187.63K-11.77%
2014-12-31$212.66K78.28%
2014-08-31$119.28K16.28%
2014-05-31$102.58K12.60%
2014-02-28$91.10K53.98%
2013-11-30$59.16K-79.95%
2013-08-31$295.05K302.99%
2013-05-31$73.21K19.08%
2013-02-28$61.48K-46.87%
2012-11-30$115.73K134.85%
2012-08-31$49.28K14.15%
2012-05-31$43.17K-25.88%
2012-02-29$58.24K-56.98%
2011-11-30$135.37K236.01%
2011-08-31$40.29K-3.13%
2011-05-31$41.59K-92.38%
2011-02-28$545.42K680.33%
2010-11-30$69.90K-87.17%
2010-08-31$544.70K237.01%
2010-05-31$161.63K100.00%
2010-01-31-100.00%
2009-10-31-100.00%
2009-04-30-100.00%
2009-01-31-100.00%
2008-10-31--

Edesa Biotech generated $50.92K in revenue during Q2 2026, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Edesa Biotech Revenue Breakdown


Edesa Biotech Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceSep 18
Product$211.85K

Edesa Biotech's latest annual revenue breakdown by segment (product or service), as of Sep 18: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceMar 19Dec 18
Product$117.75K$53.03K

Edesa Biotech's latest quarterly revenue breakdown by segment (product or service), as of Mar 19: Product (100.00%).

Edesa Biotech Revenue Breakdown by Country

Annual Revenue by Country

CountrySep 18
Product$211.85K

Edesa Biotech's latest annual revenue breakdown by geography, as of Sep 18: Product (100.00%).

Quarterly Revenue by Country

CountryMar 19Dec 18Sep 18Jun 18
Product$117.75K$53.03K$54.26K$73.05K

Edesa Biotech's latest quarterly revenue breakdown by geography, as of Mar 19: Product (100.00%).

Edesa Biotech Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
TRAWTraws Pharma$2.79B-
EVGNEvogene$5.64M$4.19M
OSRHOSR$2.91M$484.06K
IMRNImmuron$1.80M$2.36M
BRTXBioRestorative Therapies$359.70K$23.17K
DWTXDogwood Therapeutics--
IMNNImunon--
EDSAEdesa Biotech-$50.92K
COCPCocrystal Pharma-$225.00K
ERNAErnexa Therapeutics--
SNSESensei Biotherapeutics--

EDSA Revenue FAQ


What is Edesa Biotech’s yearly revenue?

Edesa Biotech's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. EDSA's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Edesa Biotech’s quarterly revenue?

Edesa Biotech's quarterly revenue for Q2 2026 was $50.92K, a 100.00% increase from the previous quarter (Q1 2026), and a 0% increase year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $0, a 100.00% increase from the previous quarter (Q4 2025), and a 0% increase year-over-year (Q1 2025). EDSA's quarterly revenue for Q4 2025 was $0, a 100.00% increase from the previous quarter (Q3 2025), and a 0% increase year-over-year (Q4 2024).

What is Edesa Biotech’s revenue growth rate?

Edesa Biotech's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.

What are Edesa Biotech’s revenue streams?

Edesa Biotech's revenue streams in p 18 are Product

What is Edesa Biotech’s main source of revenue?

For the fiscal year ending Sep 18, the largest source of revenue of Edesa Biotech was Product. This segment made a revenue of $211.85K, representing 100.00% of the company's total revenue.